Эффект бевацизумаба при папилломатозе гортани

Мансурбек Исмоилов, Shoira Makhamadaminova

Ўзбекистон метрологияси · 2026-yil

Annotatsiya

The article reviews current evidence on the efficacy and safety of bevacizumab in the treatment of recurrent laryngeal papillomatosis. It summarizes the outcomes of systemic and intralesional therapy, including their effects on recurrence rates, surgical intervals, and voice function. The findings indicate that bevacizumab is a promising adjuvant treatment that improves clinical outcomes and reduces the need for repeated surgical interventions.

Maqola ma’lumotlari
MualliflarМансурбек Исмоилов, Shoira Makhamadaminova
JurnalЎзбекистон метрологияси
Nashr sanasi2026-06-25
Jild5
Son3/S
Betlar213-217
DOI10.47689/2181-3663-vol5-iss3/s-pp213-217

Ўзбекистон метрологияси jurnalidan boshqa maqolalar

Ўзбекистон метрологияси — barcha maqolalar